194 related articles for article (PubMed ID: 33297368)
1. Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV.
Romeo MA; Santarelli R; Gilardini Montani MS; Gonnella R; Benedetti R; Faggioni A; Cirone M
Cells; 2020 Dec; 9(12):. PubMed ID: 33297368
[TBL] [Abstract][Full Text] [Related]
2. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
3. Kaposi Sarcoma Herpes Virus (KSHV) infection inhibits macrophage formation and survival by counteracting Macrophage Colony-Stimulating Factor (M-CSF)-induced increase of Reactive Oxygen Species (ROS), c-Jun N-terminal kinase (JNK) phosphorylation and autophagy.
Gilardini Montani MS; Falcinelli L; Santarelli R; Romeo MA; Granato M; Faggioni A; Cirone M
Int J Biochem Cell Biol; 2019 Sep; 114():105560. PubMed ID: 31220583
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
Katano H
Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.
Pinzone MR; Berretta M; Cacopardo B; Nunnari G
Semin Oncol; 2015 Apr; 42(2):258-71. PubMed ID: 25843730
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.
Arvanitakis L; Mesri EA; Nador RG; Said JW; Asch AS; Knowles DM; Cesarman E
Blood; 1996 Oct; 88(7):2648-54. PubMed ID: 8839859
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of selective autophagy by members of the herpesvirus ubiquitin-deconjugase family.
Ylä-Anttila P; Masucci MG
Biochem J; 2021 Jun; 478(12):2297-2308. PubMed ID: 34143865
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
9. Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV.
Shiley K; Blumberg E
Infect Dis Clin North Am; 2010 Jun; 24(2):373-93. PubMed ID: 20466275
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
Münz C
Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
Münz C
J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions.
Webster-Cyriaque J; Edwards RH; Quinlivan EB; Patton L; Wohl D; Raab-Traub N
J Infect Dis; 1997 Jun; 175(6):1324-32. PubMed ID: 9180170
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB signaling modulation by EBV and KSHV.
de Oliveira DE; Ballon G; Cesarman E
Trends Microbiol; 2010 Jun; 18(6):248-57. PubMed ID: 20452220
[TBL] [Abstract][Full Text] [Related]
14. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
Damania B; Münz C
FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
Wei F; Zhu Q; Ding L; Liang Q; Cai Q
Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
[TBL] [Abstract][Full Text] [Related]
17. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis.
Bertram G; Dreiner N; Krueger GR; Ramon A; Ablashi DV; Salahuddin SZ; Balachandram N
In Vivo; 1991; 5(3):271-9. PubMed ID: 1654150
[TBL] [Abstract][Full Text] [Related]
18. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
19. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection and expression in oral lesions.
Raab-Traub N; Webster-Cyriaque J
Oral Dis; 1997 May; 3 Suppl 1():S164-70. PubMed ID: 9456682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
